🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Rectal Cancer Stage III

Sacituzumab Govitecan in Metastatic Colorectal Cancer NCT06243393Phase 2, Phase 31 site📍 Heidelberg University Hospital Heidelberg · Tests: Sacituzumab Govitecan (SG), Physicians Choice (PhC). Neoadjuvant Therapy With Tislelizumab for dMMR/MSI-H Stage II-III Colorectal Cancer NCT07352280n/a1 site📍 Beijing Cancer Institute and Hospital, Chinese Academy of Medical S… Neoadjuvant Botensilimab and Balstilimab for the Treatment of Advanced Resectable Colorectal Cancer NEST3 NCT07595874Phase 211 sites📍 Goodyear📍 Corona📍 Duarte City of Hope Medical Center · Tests: Balstilimab, Biospecimen Collection, Botensilimab, Computed Tomography, Magnetic Resonance Imaging Comparing Efficacy and Safety of Enlituo® Versus Erbitux® Plus FOLFOX in Locally Advanced/Metastatic Colorectal Cancer With RAS/BRAF Wild-type and MSS/pMMR Status. NCT07595276Phase 31 site📍 Guangzhou Taizhou Mabtech Pharmaceutical Co.,Ltd · Tests: Enlituo®, Erbitux® DOSAGE Study: Upfront Dose-Reduced Chemotherapy in Older Patients with Metastatic Colorectal Cancer NCT06275958Phase 336 sites📍 's-Hertogenbosch📍 Alkmaar📍 Amstelveen Leiden University Medical Center · Tests: Doublet Chemotherapy, Standard Dose (100%), Doublet Chemotherapy, Dose-reduced (75%), Monotherapy, Standard Dose (100%)… UGT1A1-Based Irinotecan Therapy for Locally Advanced Rectal Cancer NCT05148767Phase 41 site📍 Hangzhou Zhejiang Cancer Hospital · Tests: Neoadjuvant chemoradiotherapy based on irinotecan Neoadjuvant CAPOX With or Without Pucotenlimab Plus Selective Radiotherapy for Locally Advanced Rectal Cancer NCT07528209Phase 31 site📍 Guangzhou Sun Yat-sen University · Tests: Pucotenlimab combine with CAPOX, CAPOX A Study of 2nd-line FOLFIRI ± Bevacizumab vs. Irinotecan ± Bevacizumab in mCRC NCT03303495Phase 31 site📍 Guangzhou Sun Yat-sen University · Tests: Bevacizumab, CPT-11, 5-FU Bolus, 5-FU Infusion, l-LV (dl-LV) A Randomized Controlled Trial of Plasma ctDNA Methylation-Guided Adjuvant Chemotherapy Decision-Making in High-Risk Stage III (T4N+ or T1-3N2) Colorectal Cancer NCT07562490Phase 21 site📍 Shanghai Fudan University · Tests: FOLFOX, Folfox plus Bevacizumab Short-Course Radiotherapy Followed by CAPOX With or Without Iparomlimab and Tuvonralimab in pMMR/MSS Locally Advanced Rectal Cancer NCT07686640Phase 31 site📍 Jinan Shandong Cancer Hospital and Institute · Tests: Short-Course Radiotherapy, Consolidation treatment (With ICIs), Consolidation treatment (Without ICIs) A Study of Meaning-Centered Therapy for Mexican Adults With Advanced Cancer NCT07225309NA2 sites📍 New York📍 Mexico City Memorial Sloan Kettering Cancer Center · Tests: Meaning-Centered Psychotherapy for Latinos /MCP-L Other Oncogene Mutations for Anti-EGFR Efficacy in Patients With Left-sided RAS-wild Type Metastatic Colorectal Cancer NCT06226857Phase 33 sites📍 Moscow📍 Moscow📍 Reutov City Clinical Oncology Hospital No 1 · Tests: Cetuximab The Utility and Feasibility of Mt-sDNA as a Surveillance Procedure in Colorectal Cancer Survivors NCT04624555n/a1 site📍 Cleveland Case Comprehensive Cancer Center Surgery Plus Chemo Versus Chemoradiotherapy Followed by Surgery Plus Chemo for Locally Recurrent Rectal Cancer NCT04288999Phase 345 sites📍 Chiba📍 Gifu📍 Hidaka National Cancer Center Hospital East · Tests: Chemotherapy, Preoperative radiotherapy, Procedure ctDNA Monitoring to Predict the Efficacy of TNT for Rectal Cancer NCT06589388n/a1 site📍 Ho Chi Minh City Gene Solutions Zanzalintinib Alone or in Combination With Pembrolizumab and Berahyaluronidase Alfa in Participants With Colorectal Cancer With Molecular Residual Disease NCT07750158Phase 313 sites📍 Council Bluffs📍 Grand Island📍 Grand Island Exelixis · Tests: Zanzalintinib, Pembrolizumab (+) Berahyaluronidase alfa, Placebo Evaluation of Quality of Life and Utilities Following Surgical Treatment of Stage I-IV Rectal Cancer NCT02107105n/a1 site📍 Houston M.D. Anderson Cancer Center · Tests: Quality-of-Life Assessment, Questionnaire Administration Adjuvant Chemotherapy Combined With Targeted Therapy or Not in the T3-4N2 Colorectal Cancer Patients NCT05797467Phase 31 site📍 Guangzhou Sixth Affiliated Hospital, Sun Yat-sen University · Tests: FOLFOX chemotherapy regimens, Bevacizumab Early Detection of Advanced Adenomas and Colorectal Cancer NCT06342440n/a6 sites📍 Monrovia📍 San Diego📍 Dalian City of Hope Medical Center · Tests: DENEB Immune Checkpoint Inhibitor Response in Solid Tumors Using a Live Tumor Diagnostic Platform NCT06349642n/a3 sites📍 Phoenix📍 Jacksonville📍 Rochester Mayo Clinic · Tests: Biospecimen Collection, Tissue Collection Ganglion Impar Neurolysis for the Improvement of Radiation-Induced Pain During Localized Anal or Perianal Skin Cancer Treatment NCT07112690NA2 sites📍 Atlanta📍 Atlanta Emory University · Tests: Electronic Health Record Review, Fluoroscopy, Ganglion Impar Neurolysis, Questionnaire Administration Magnetic Resonance Tumour Regression Grade (mrTRG) as a Novel Biomarker - Phase III Non CTIMP Trial NCT02704520NA10 sites📍 Aberdeen📍 Basingstoke📍 Stoke-on-Trent Imperial College London · Tests: High resolution MRI scan, mrTRG assessment MRD-guided Deferred Adjuvant Therapy in Resectable Early-stage Colon Cancer NCT06204484NA1 site📍 Guangzhou Sun Yat-sen University · Tests: CAPEOX adjuvant therapy, deferred CAPEOX adjuvant therapy, mFOLFOXIRI intensive adjuvant therapy Clinical Research on the Treatment Model of Ambulatory Surgery for Colorectal Cancer NCT06637215NA1 site📍 Shenyang First Hospital of China Medical University · Tests: laparoscopic colorectal day surgery, traditional laparoscopic colorectal surgery A Study of Tucidinostat in Combination With Sintilimab and Bevacizumab in MSS/pMMR Colorectal Cancer Patients NCT06497985Phase 31 site📍 Guangzhou Chipscreen Biosciences, Ltd. · Tests: Tucidinostat, Sintilimab, Bevacizumab, Fruquintinib Comparison of In-Home Versus In-Clinic Administration of Subcutaneous Nivolumab Through Cancer CARE (Connected Access and Remote Expertise) Beyond Walls (CCBW) Program NCT06265285Phase 21 site📍 Jacksonville Mayo Clinic · Tests: Home Health Encounter, Nivolumab, Patient Monitoring, Questionnaire Administration GUIDE.MRD-01-CRC: Clinical Validation and Benchmarking of Top Performing ctDNA Diagnostics - Colorectal Cancer NCT06111105n/a15 sites📍 Graz📍 Graz📍 Copenhagen Claus Lindbjerg Andersen mFOLFOX6 + Bevacizumab + PD-1 Monoclonal Antibody Vs. mFOLFOX6 in Locally Advanced pMMR/MSS CRC NCT06791512Phase 31 site📍 Guangzhou Jun Huang · Tests: mFOLFOX6 + Bevacizumab + PD-1 monoclonal antibody, mFOLFOX6 FAPI-Guided Radiotherapy With Cadonilimab and Standard Chemotherapy for Colorectal Peritoneal Metastasis: A Phase III Randomized Controlled Trial (TORHC-PM02) NCT07815834Phase 31 site📍 Shanghai Fudan University · Tests: Second-Line Chemotherapy, Radiation Therapy, Cadonilimab (AK104) Non Inferiority Study of Preoperative Chemotherapy Without Pelvic Irradiation for Rectal Cancer NCT03875781Phase 31 site📍 Le Kremlin-Bicêtre Assistance Publique - Hôpitaux de Paris · Tests: Chemotherapy, Radiochemotherapy
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy